The Relationship Between Microbiota and Coronary Ectasia
Completed
- Conditions
- Microbial DiseaseCoronary Ectasia
- Registration Number
- NCT06384703
- Lead Sponsor
- Konya Beyhekim Training and Research Hospital
- Brief Summary
Introduction: It is now known that the microbiota is far beyond the microbial communities living in certain parts of our body and functions like a metabolic organ. In addition, the microbiota, through its metabolites, is involved in the pathophysiology or progression of a wide range of diseases, from atherosclerotic diseases to metabolic diseases and even neurological diseases. Among these metabolites, trimethylamine n-oxide metabolite has been shown to be particularly effective on atherosclerotic heart diseases.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2
Inclusion Criteria
- over 18 years old
- not having occlusive coronary artery disease
- having coronary ectasia
Exclusion Criteria
- patients with chronic kidney disease,
- revascularized coronary artery disease,
- previously documented critical coronary stenosis,
- acute or chronic inflammatory disease,
- rheumatologic disease,
- known active malignant disease,
- heart failure,
- moderate-to-severe valvular pathology
- patients who were on any steroid or immunosuppressive therapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method death 1 month Death from any cause within the last month
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Necmettin Erbakan University
🇹🇷Konya, Turkey
Necmettin Erbakan University🇹🇷Konya, Turkey